Molecular signatures that can be transferred across different omics platforms
Michael Altenbuchinger(Universitätsmedizin Göttingen), Rainer Spang(Howard Hughes Medical Institute), Monika Szczepanowski(Christian-Albrechts-Universität zu Kiel), N Masqué-Soler(Christian-Albrechts-Universität zu Kiel), Julia Richter(German Cancer Research Center), P Schwarzfischer(University of Regensburg), Ch. W Kohler(University of Regensburg), Jörg Reinders(TU Dortmund University), Wolfram Gronwald(University of Regensburg), T Rehberg(University of Regensburg), P J Oefner(University of Regensburg)
Cited by 15
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
|New England Journal of Medicine|2006|1k
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry
|The Lancet Oncology|2015|613
Combined chemical shift changes and amino acid specific chemical shift mapping of protein–protein interactions
|Journal of Biomolecular NMR|2007|236